Prospective clinical study for artificial intelligence platform for lymph node pathology detection of gastric cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900023282

Enrollment

Unknown

Registered

2019-05-20

Start date

2019-09-01

Completion date

Unknown

Last updated

2019-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

1:Pathological Diagnosis of Artificial Intelligence

2:Traditional pathological diagnosis

Eligibility

Sex/Gender

All

Age

40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 40-70 years with gastric cancer; 2. Gastric cancer patients were treated by operation; 3. Surgery is radical.

Exclusion criteria

Exclusion criteria: 1. Complicated with diabetes mellitus, rheumatic immune diseases, serious heart, brain and kidney and other systemic diseases; 2.Refuse to sign informed consent.

Design outcomes

Primary

Measure	Time frame
Clinical prognosis;	—

Secondary

Measure	Time frame
Quality of life after treatment;lifetime;	—

Countries

China

Contacts

Public ContactLu Yun

Affiliated Hospital of Qingdao University

cloudylucn@126.com+86 18661802231

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026